BioCentury | Apr 21, 2020
Product Development

April 20 Quick Takes: Top-line data for BMS, Idorsia and Ascendis; plus Otsuka-Esperion, Regeneron and more

...trial of TransCon PTH in 4Q20 after Phase II data showed the sustained-release prodrug of PTH...
...HCRTR2) - Orexin 2 receptor PD-1 (PDCD1; CD279) - Programmed cell death 1 PTH - parathyroid hormone...
...CD152) Programmed cell death 1 (PD-1) (PDCD1) (CD279) Orexin 1 receptor (OX1R) (HCRTR1) Orexin 2 receptor (OX2R) (HCRTR2) Parathyroid hormone (PTH) REGN-EB3...
BioCentury | Jul 31, 2019
Financial News

Alizé seeks to build out company with largest European A round this year

...has two programs that are expected to enter the clinic next year: AZP-3601 is a PTH...
...which had an initial close of €465 million ($519 million) this year. Targets: PTH - parathyroid hormone...
...factor binding protein 2 Stephen Hansen, Associate Editor Alize Pharma LSP Insulin-like growth factor (IGF) binding protein 2 (IGFBP2) Parathyroid hormone (PTH...
BioCentury | Aug 3, 2018
Clinical News

Amgen's Blincyto among negative CHMP opinions

...communicated to the company its negative trend vote. Abaloparatide-SC is a subcutaneous peptide analog of parathyroid hormone-related...
BioCentury | Jul 27, 2018
Company News

New Blincyto indication among negative CHMP opinions

...communicated to the company its negative trend vote. Abaloparatide-SC is a subcutaneous peptide analog of parathyroid hormone-related...
BioCentury | Jun 29, 2018
Financial News

Tricida, Translate Bio, Forty Seven and Entera price IPOs

...shares and warrants will trade under separate tickers. Entera is developing an oral version of parathyroid hormone...
BioCentury | Jun 28, 2018
Financial News

Tricida gains, others dip after upsized IPOs

...shares and warrants will trade under separate tickers. Entera is developing an oral version of parathyroid hormone...
BioCentury | Jun 20, 2018
Company News

Management tracks: Sanofi, NantKwest

...Alan Kranser as CMO. He was senior medical director and global development lead for Natpara parathyroid hormone...
BioCentury | Apr 24, 2018
Distillery Therapeutics

Musculoskeletal

...vehicle, and decreased trabecular separation with potencies comparable to, or higher than, standard of care parathyroid hormone...
BioCentury | Mar 30, 2018
Clinical News

CHMP brushes off Radius osteoporosis treatment

...Radius said it plans to request a re-examination. Abaloparatide-SC is a subcutaneous peptide analog of parathyroid hormone-related...
...Injection) Business: Musculoskeletal Allison Johnson Tymlos (BA058-SC, ITM-058, abaloparatide-sc, ba058 injection, eladynos, BIM44058) Ipsen Group Radius Health Inc. Teijin Pharma Ltd. Parathyroid hormone-like...
BioCentury | Mar 23, 2018
Company News

CHMP rebuffs Portola's betrixaban, Radius' abaloparatide-SC

...Radius said it plans to request a re-examination. Abaloparatide-SC is a subcutaneous peptide analog of parathyroid hormone-related...
Items per page:
1 - 10 of 802